Bladder cancer is one of the common malignant urothelial tumors. Post-translational modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation, have been revealed to participate in bladder cancer initiation and progression. Ubiquitination is the common PTM, which is conducted by E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme and E3 ubiquitin-protein ligase. E3 ubiquitin ligases play a key role in bladder oncogenesis and progression and drug resistance in bladder cancer. Therefore, in this review, we summarize current knowledge regarding the functions of E3 ubiquitin ligases in bladder cancer development. Moreover, we provide the evidence of E3 ubiquitin ligases in regulation of immunotherapy in bladder cancer. Furthermore, we mention the multiple compounds that target E3 ubiquitin ligases to improve the therapy efficacy of bladder cancer. We hope our review can stimulate researchers and clinicians to investigate whether and how targeting E3 ubiquitin ligases acts a novel strategy for bladder cancer therapy.

/pdf/the-role-of-e3-ubiquitin-ligases-and-deubiquitinases-in-1jy933aj.pdf

The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy

/pdf/correction-to-the-function-and-mechanisms-of-action-of-78lf1gsg.pdf

Correction to: The function and mechanisms of action of circular RNAs in Urologic Cancer

Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions.

Non-coding RNAs in renal cell carcinoma: Implications for drug resistance.

Abstract Kidney, bladder, and prostate cancer are the three major tumor types of the urologic system that seriously threaten human health. Circular RNAs (CircRNAs), special non-coding RNAs with a stabile structure and a unique back-splicing loop-forming ability, have received recent scientific attention. CircRNAs are widely distributed within the body, with important biologic functions such as sponges for microRNAs, as RNA binding proteins, and as templates for regulation of transcription and protein translation. The abnormal expression of circRNAs in vivo is significantly associated with the development of urologic tumors. CircRNAs have now emerged as potential biomarkers for the diagnosis and prognosis of urologic tumors, as well as targets for the development of new therapies. Although we have gained a better understanding of circRNA, there are still many questions to be answered. In this review, we summarize the properties of circRNAs and detail their function, focusing on the effects of circRNA on proliferation, metastasis, apoptosis, metabolism, and drug resistance in kidney, bladder, and prostate cancers. 

/pdf/the-function-and-mechanisms-of-action-of-circular-rnas-in-1h02h63i.pdf

Sheng-Feng Zheng

Papers

The function and mechanisms of action of circular RNAs in Urologic Cancer

Correction to: The function and mechanisms of action of circular RNAs in Urologic Cancer